Merck KGaA (OTCMKTS:MKKGY) Sees Significant Decline in Short Interest

Merck KGaA (OTCMKTS:MKKGY - Get Free Report) saw a large decrease in short interest in March. As of March 15th, there was short interest totalling 900 shares, a decrease of 88.9% from the February 28th total of 8,100 shares. Based on an average daily volume of 129,800 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company's shares are sold short.

Merck KGaA Trading Up 1.7 %

OTCMKTS MKKGY traded up $0.48 during trading hours on Friday, hitting $28.23. 163,046 shares of the company's stock were exchanged, compared to its average volume of 126,789. Merck KGaA has a 1-year low of $27.19 and a 1-year high of $39.17. The company has a current ratio of 1.33, a quick ratio of 0.91 and a debt-to-equity ratio of 0.28. The stock has a 50-day simple moving average of $29.13 and a 200 day simple moving average of $30.93. The firm has a market cap of $18.24 billion, a price-to-earnings ratio of 17.43, a PEG ratio of 2.05 and a beta of 0.98.

Merck KGaA (OTCMKTS:MKKGY - Get Free Report) last released its quarterly earnings data on Thursday, March 6th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.07. The company had revenue of $5.78 billion during the quarter, compared to analyst estimates of $5.40 billion. Merck KGaA had a net margin of 12.89% and a return on equity of 10.41%. On average, equities analysts forecast that Merck KGaA will post 1.87 EPS for the current fiscal year.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.